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Differential Changes in the Peptidergic and the
Non-Peptidergic Skin Innervation in Rat Models for
Inﬂammation, Dry Skin Itch, and Dermatitis
Barthold N. Schüttenhelm1,2, Liron S. Duraku1,2, Jouke F. Dijkstra1, Erik T. Walbeehm3 and Jan C. Holstege1
Skin innervation is a dynamic process that may lead to changes in nerve ﬁber density during pathological
conditions. We have investigated changes in epidermal nerve ﬁber density in three different rat models that
selectively produce chronic itch (the dry skin model), or itch and inﬂammation (the dermatitis model), or chronic
inﬂammation without itch (the CFA model). In the epidermis, we identiﬁed peptidergic ﬁbers—that is,
immunoreactive (IR) for calcitonin gene-related peptide or substance P—and non-peptidergic ﬁbers—that is, IR
for P2X3. The overall density of nerve ﬁbers was determined using IR for the protein gene product 9.5. In all three
models, the density of epidermal peptidergic nerve ﬁbers increased up to ﬁve times when compared with a
sham-treated control group. In contrast, the density of epidermal non-peptidergic ﬁbers was not increased,
except for a small but signiﬁcant increase in the dry skin model. Chronic inﬂammation showed an increased
density of peptidergic ﬁbers without itch, indicating that increased nerve ﬁber density is not invariably associated
with itch. The ﬁnding that different types of skin pathology induced differential changes in nerve ﬁber density
may be used as a diagnostic tool in humans, through skin biopsies, to identify different types of pathology and to
monitor the effect of therapies.
Journal of Investigative Dermatology (2015) 135, 2049–2057; doi:10.1038/jid.2015.137; published online 7 May 2015
INTRODUCTION
Sensory information from the skin is collected by many types
of receptors or receptor organs, which pass on the information
through a variety of nerve ﬁbers (Basbaum et al., 2009).
Nociceptive ﬁbers are involved in signaling temperature
information, as well as potential and actual damaging stimuli
of a mechanical or a chemical nature, including itch.
Nociceptive ﬁbers are extensively present in the epidermis
and consist mainly of thinly myelinated A-delta and unmye-
linated C-ﬁbers, which are commonly subdivided into
peptidergic and non-peptidergic ﬁbers that all use glutamate
as a transmitter (Basbaum et al., 2009). In addition, peptidergic
ﬁbers contain the neuropeptides calcitonin gene–related
peptide (CGRP) and/or substance P (SubP; Ruscheweyh
et al., 2007), whereas non-peptidergic ﬁbers characteristically
contain the purinergic receptor P2X3 (Taylor et al., 2009) and
the lectin IB4 (Plenderleith and Snow, 1993; Petruska et al.,
1997; Bradbury et al., 1998). Skin innervation is a dynamic
process, especially during pathological skin conditions, when
major changes in nerve ﬁber density have been observed in
the skin. These changes may be used as an additional and an
objective instrument to identify or conﬁrm the type (and stage)
of a pathological process. Until now, changes in the
expression of peptides and receptors during pathological
conditions, like chronic itch and chronic inﬂammation, have
been identiﬁed in dorsal root ganglia (Xu et al., 2005; Chien
et al., 2007; Akiyama et al., 2013), whereas knowledge about
changes in epidermal nerve ﬁbers in these pathological
conditions associated with chronic itch or chronic inﬂam-
mation is still limited. Similarly, after axotomy, a large number
of changes occur (Xiao et al., 2002), which have been studied
extensively in dorsal root ganglion cells, whereas the resulting
changes in the periphery received only a limited amount of
attention (Lauria et al., 2005; Almarestani et al., 2008; Duraku
et al., 2013).
In the present study, we have focused on changes in the
innervation density of epidermal nerve ﬁbers in the skin
during chronic itch and chronic inﬂammation. Presently, a
detailed analysis of these changes for the different ﬁber types
is lacking, especially regarding the non-peptidergic ﬁbers that
account for 60% of the epidermal innervation in unaffected
skin (Taylor et al., 2009). The inhibition of nerve ﬁber growth
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reduces itch in atopic dermatitis (Negi et al., 2012), which
may indicate that changes in skin innervation are directly
involved in the induction of itch and inﬂammation. The ﬁrst
step to unravel this relationship is to deﬁne the exact changes
occurring in the skin innervation during chronic itch and
inﬂammation.
In this study, we investigated the changes in the density of
peptidergic and non-peptidergic ﬁbers occurring in the
epidermis and upper dermis during chronic itch and during
chronic inﬂammation using three different animal models: the
dry skin model (Akiyama et al., 2010), which has been shown
to induce itch without inﬂammation, the dermatitis model
(Fujii et al., 2009), which induces itch accompanied by
inﬂammation, and the complete Freund’s adjuvant (CFA) model,
which is widely used as a model of chronic inﬂammation
without itch (Stein et al., 1988; Hossaini et al., 2010).
We found that, in all three models, the density of epidermal
peptidergic nerve ﬁbers (CGRP-immunoreactive (IR) and
SubP-IR) increased when compared with the control group.
In contrast, the density of the epidermal non-peptidergic ﬁbers
(P2X3-IR) was not increased, except for a small but a
signiﬁcant increase in the dry skin model. These differential
changes in nerve ﬁber density may be used in future as a
diagnostic tool, through skin biopsies, to identify different
types of skin pathology and changes induced by speciﬁc
therapies.
RESULTS
This study aims to identifying changes in nerve ﬁber density in
the skin during chronic itch and inﬂammation using three
different models that produce chronic itch (dry skin model),
chronic itch and inﬂammation (dermatitis model), or chronic
inﬂammation (CFA model). We veriﬁed the effects of each
treatment by performing several behavioral experiments.
Then, epidermal nerve ﬁber densities were quantiﬁed in the
three models with a focus on peptidergic and non-peptidergic
ﬁbers.
Veriﬁcation of the animal models
The behavioral experiments were performed in order to
determine whether the applied treatment in the chronic itch
and inﬂammation models actually resulted in the correspond-
ing behavior. A signiﬁcant increase in biting behavior was
observed, suggestive of a pruritic stimulus (Shimada and
Lamotte, 2008) in the dry skin model and in the dermatitis
model compared with control but not in the CFA model. No
licking, suggestive of the presence of pain (Shimada and
Lamotte, 2008),was observed in any of the models. Regarding
the mechanical hypersensitivity, no changes were observed
for the dry skin model compared with the control group,
whereas for the dermatitis model and the CFA model a
signiﬁcant decrease in the mechanical hypersensitivity
threshold was observed.
Examination of the skin sections stained with hematoxylin
and eosin or processed for CD68 immunohistochemistry
showed clear signs of inﬂammatory inﬁltrates in the dermatitis
and the CFA models, whereas these signs were absent in the
controls and the dry skin model. These ﬁndings are in line
with the macroscopic observations (see the Supplementary
data online section for details).
Epidermal nerve ﬁber density
From each rat, the skin of the treated foot sole was collected
and processed for immunocytochemistry using antibodies
against CGRP and SubP for identifying peptidergic ﬁbers and
against P2X3 for identifying non-peptidergic ﬁbers. In order to
stain all ﬁbers present in the epidermis antibodies against
PGP9.5 were used. The skin sections were examined in a light
microscope, and the epidermal density of each type of
nerve ﬁber was determined. Previous ﬁndings have shown
differences in the density of nerve ﬁbers in the skin of
the footpad area compared with the non-footpad area of the
rat hind paw (Duraku et al., 2012; 2013). Therefore, in this
study, we quantiﬁed the peptidergic and the non-peptidergic
nerve ﬁbers in the skin of footpad and non-footpad areas
separately.
The density of peptidergic nerve ﬁbers in the epidermis. In all
three models, the number of CGRP (Figure 1) and SubP-IR
(Figure 2) peptidergic ﬁbers in the epidermis was assessed
separately in the footpad and the non-footpad areas at 2 and
4 weeks after treatment and compared with control. In both the
dry skin and the dermatitis models, the CGRP-IR ﬁber density
showed an increase (Figure 1). This increase was signiﬁcant in
the footpad area after 2 weeks, whereas in the non-footpad area
this increase was signiﬁcant only after 4 weeks of treatment. In
contrast, in the CFA model, a signiﬁcantly increased CGRP-IR
nerve ﬁber density was observed at 2 weeks after the treatment in
both the non-footpad and the footpad areas, which had returned
to control levels at 4 weeks after treatment.The density of SubP-IR
ﬁbers was about 50% lower compared with the CGRP ﬁber
density, and it showed a similar pattern of increasing density in
all three models (Figure 2). Exceptions to this overall increase in
peptidergic ﬁbers were found in the dermatitis model where the
increase in the non-footpad area was already signiﬁcant after
2 weeks. Furthermore, in the CFA model, the density the SubP-IR
ﬁbers, after an initial increase at 2 weeks, did not return to control
levels after 4 weeks in contrast to the CGRP ﬁbers. This was
observed both in the footpad and the non-footpad areas.
The density of non-peptidergic nerve ﬁbers in the epidermis.
The P2X3 marker was used to identify non-peptidergic ﬁbers in
the epidermis (Figure 3). The density of P2X3-IR ﬁbers was not
signiﬁcantly increased except for a small but a signiﬁcant
increase in the dry skin model after 2 weeks and 4 weeks of
treatment in the footpad area and in the non-footpad area after
4 weeks of treatment.
The density of all types of nerve ﬁbers in the epidermis. As a
control for the previous stainings, we used the PGP9.5 marker in
order to stain simultaneously all types of nerve ﬁbers in the skin
(Figure 4). In the dry skin rats, we observed a signiﬁcant increase
in the density of epidermal nerve ﬁbers after 2 and 4 weeks of
treatment in the footpad areas and after 4 weeks in the non-
footpad areas when compared with the control group. In the
dermatitis model, a signiﬁcant increase in the density of
epidermal nerve ﬁbers was found after 2 and 4 weeks of
treatment in the footpad areas and after 4 weeks in the non-
footpad areas. In the CFA model, the density of epidermal ﬁbers
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Figure 1. Density of calcitonin gene-related peptide (CGRP)-immunoreactive (IR) epidermal nerve ﬁbers. (a) Micrographs showing CGRP-IR ﬁbers in the
footpad area from control rats, rats treated following the dry skin model, the dermatitis model, or the complement Freund’s adjuvant (CFA) model. The dotted line
indicates the boundary between the epidermis and the upper dermis. (b) Histograms showing the density of epidermal CGRP–positive ﬁbers in controls (Ctrl;
n= 6), in the dry skin model (DS; n=6), in the dermatitis model (De; n=6), and in the CFA model (CFA; n=6) in the footpad and non-footpad areas after 2 weeks
and 4 weeks of treatment. Analysis was performed by using the one-way analysis of variance with a Tukey’s post hoc test. All comparisons were made with the
control group (*Po0.05; **Po0.01; ***Po0.001). The error bars denote the mean± SEM. (Bar= 30 μm).
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Figure 2. Density of SubP-immunoreactive (IR) epidermal nerve ﬁbers. (a) Micrographs showing SubP-IR ﬁbers in the footpad area from control rats, rats treated
following the dry skin model, the dermatitis model, or the complement Freund’s adjuvant (CFA) model. The dotted line indicates the boundary between the
epidermis and the upper dermis. (b) Histograms showing the number of epidermal SubP-IR ﬁbers in controls (Ctrl; n=6), in the dry skin model (DS; n= 6), in the
dermatitis model (De; n=6), and in the CFA model (CFA; n=6) in the footpad and non-footpad areas after 2 weeks and 4 weeks of treatment. Analysis was
performed by using the one-way analysis of variance with a Tukey’s post hoc test. All comparisons were made with the control group (**Po0.01; ***Po0.001).
The error bars denote the mean± SEM. (Bar= 30 μm).
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Figure 3. Density of P2X3-immunoreactive (IR) epidermal nerve ﬁbers. (a) Micrographs showing P2X3-IR ﬁbers in the non-footpad area from control rats, rats
treated following the dry skin model, the dermatitis model, or the complement Freund’s adjuvant (CFA) model. The dotted line indicates the boundary between
the epidermis and the upper dermis. (b) Histograms showing the number of epidermal P2X3-IR ﬁbers in controls (Ctrl; n=6), in the dry skin model (DS; n=6), in
the dermatitis model (De; n=6), or in the CFA model (CFA; n=6) in the footpad and non-footpad areas after 2 weeks and 4 weeks of treatment. Analysis was
performed by using the one-way analysis of variance with a Tukey’s post hoc test. All comparisons were made with the control group (*Po0.05; **Po0.01). The
error bars denote the mean± SEM. (Bar=30 μm).
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Figure 4. Density of protein gene product 9.5 (PGP9.5)-immunoreactive (IR) epidermal nerve ﬁbers. (a) Micrographs showing PGP9.5-IR ﬁbers in the foopad
area from control rats, rats treated following the dry skin model, the dermatitis model, or the complement Freund’s adjuvant (CFA) model. The dotted line
indicates the boundary between the epidermis and the upper dermis. (b) Histograms showing the number of epidermal PGP9.5-IR ﬁbers in controls (Ctrl; n= 6), in
the dry skin model (DS; n= 6), in the dermatitis model (De; n= 6), or in the CFA model (CFA; n=6) in the footpad and non-footpad areas after 2 weeks and
4 weeks of treatment. Analysis was performed by using the one-way analysis of variance with a Tukey’s post hoc test. All comparisons were made with the control
group (*Po0.05; **Po0.01; ***Po0.001). The error bars denote the mean± SEM. (Bar=30 μm).
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increased signiﬁcantly 2 weeks after the ﬁrst treatment but was
not increased after 4 weeks.
Upper dermal nerve ﬁber density
Nerve ﬁbers were also counted in the upper dermal layer, just
underneath the epidermis. The number of ﬁbers that were IR
to either CGRP, SubP, P2X3, or PGP9.5 was counted in the
upper dermis of the footpad and the non-footpad areas. There
were no signiﬁcant differences (P40.05) in the upper dermal
nerve ﬁber density in the dry skin model, in the dermatitis
model, nor in the CFA model compared with the control
group (data not shown).
DISCUSSION
In the present study, changes in the density of nerve ﬁbers IR
for CGRP, SubP, P2X3, and PGP9.5 in the epidermis and in
the upper dermis were investigated in two chronic itch
models—namely, the dry skin model and the dermatitis
model—and in a chronic inﬂammation model without itch.
The results, summarized in Table 1, showed that, in all three
models, the density of epidermal peptidergic nerve ﬁbers
(CGRP-IR and SubP-IR) increased when compared with the
control group. In contrast, the density of the epidermal non-
peptidergic ﬁbers (P2X3-IR) was not increased except for a
small but a signiﬁcant increase in the dry skin model. A
signiﬁcant decrease in ﬁber density was never seen.
Itch and hypersensitivity
In order to determine whether the various animal models
actually showed the corresponding behavior, the cumulative
duration of scratching bouts and the mechanical sensi-
tivity were determined. In the dry skin model, our data
showed an increase in scratching behavior compared
with control animals, whereas the mechanical sensitivity
thresholds remained unchanged, as previously described
(Akiyama et al., 2010). This implies that the dry skin model
induced itch without hypersensitivity, indicating that there
was no inﬂammatory component. The dermatitis model also
showed an increase in scratching behavior but now
accompanied by lower mechanical thresholds. This hyper-
sensitivity indicates that the application of dinitrochloro-
benzene to induce itch also induced inﬂammation, as noted
previously (Fujii et al., 2009; Park and Oh, 2014). The CFA
model showed a signiﬁcant increase in mechanical sensitivity
without an increase in scratching behavior, indicating that this
model induced inﬂammation without itch (Hossaini et al.,
2010). During the behavioral observations, no licking of the
hind paw, which is indicative of pain behavior (Shimada
and Lamotte, 2008), was observed in any of the models.
Examination of the skin sections stained with hematoxylin and
eosin or processed for CD68 immunohistochemistry showed
clear signs of inﬂammatory inﬁltrates in the dermatitis and the
CFA models, whereas these signs were absent in the controls
and the dry skin model. Thus, the behavioral ﬁndings together
with the histological examinations showed that the dry skin
model induced chronic itch without inﬂammation, that the
dermatitis model induced itch with an inﬂammatory com-
ponent, and that the CFA model induced inﬂammation
without itch.
Immunohistochemistry of nerve ﬁbers in the skin
In this study, we have used immunohistochemistry to identify
various ﬁber types in the skin. Antibodies against the peptides
CGRP and SubP were used to identify peptidergic ﬁbers.
These peptides are colocalized (Basbaum et al., 2009) such
that all SubP-IR ﬁbers also contain CGRP but not vice versa
(Gibbins et al., 1987; Ju et al., 1987). In accordance, we found
that most changes in CGRP-IR ﬁber density were also
reﬂected in the changes in the SubP-IR ﬁber density, indicat-
ing that the same types of ﬁbers were involved. In some cases,
however, the increase in ﬁber density was higher for SubP
than for CGRP. This may be due to a relative increase in SubP-
IR ﬁbers within the CGRP-IR ﬁber population. In order to label
non-peptidergic ﬁbers—that is, ﬁbers that do not contain the
peptides CGRP or SubP—we have used an antibody directed
against the P2X3 receptor, which is not or hardly expressed in
peptidergic ﬁbers (Chen et al., 1995; Lewis et al., 1995;
Vulchanova et al., 1998). In the remainder of the discussion,
we will focus on the peptidergic (i.e., CGRP- and SubP-IR)
and the non-peptidergic (i.e., P2X3-IR) ﬁbers. This distinction
is highly relevant, as these ﬁbers terminate in different layers
of the spinal cord and have different properties (Vulchanova
et al., 1998; Basbaum et al., 2009). An increased density of
the IR nerve ﬁbers may be due to either sprouting—that is, an
increase in the number of ﬁbers present in the epidermis—or
to an increase in the expression of the peptides or the P2X3
receptor in existing ﬁbers that, in the control situation,
remained below the detection level of the immuno-histo-
Table 1. Semi-quantitative summary of the changes in
epidermal nerve ﬁber density1
Dry skin model Dermatitis model CFA model
2 weeks 4 weeks 2 weeks 4 weeks 2 weeks 4 weeks
CGRP
FP ++++2 ++++ ++++ ++++ +++ ns
NFP ns ++ ns ++ ++ ns
SubP
FP +++ ++++ ++++ ++++ ++++ ++++
NFP ns ++++ +++ +++ ++++ ++++
P2X3
FP + + ns ns ns ns
NFP ns + ns ns ns ns
PGP9.5
FP +++ +++ ++ ++ ++ +
NFP ns + + + + ns
Abbreviations: CFA, complement Freund’s adjuvant; CGRP, calcitonin
gene-related peptide; NF, footpad area; NFP, non-footpad area; ns, non
signiﬁcant; PGP9.5, protein gene product 9.5; SubP, substance P.
1On the basis of the results shown in Figures 1,2,3,4.
2+: between 10 and 50% increase; ++: between 50 and 100% increase.
+++: between 100 and 200% increase; ++++: between 200 and 400%
increase.
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chemical procedure. In order to differentiate between these
two possibilities, we used the PGP9.5 antibody that stains the
entire nerve ﬁber population in the skin, as it recognizes
ubiquitin carboxyl-terminal hydrolase, a protein that is present
in all nerve ﬁbers (Wilkinson et al., 1989). In nearly all cases,
the increased density of both the peptidergic ﬁber density and
the non-peptidergic ﬁber density is accompanied by an
increased density of PGP9.5-IR ﬁbers. Thus, at least part of
the increased ﬁber density is due to the sprouting of ﬁbers rather
than an increase in the immunoreactivity of existing ﬁbers.
Footpad and non-footpad areas
In the footpad areas of the control skin, there were less pepti-
dergic and non-peptidergic ﬁbers than in the non-footpad
areas as we have shown previously (Duraku et al., 2012;
2013). The difference is mainly in the time points at which the
ﬁber density increases, appearing earlier in the footpad than
in the non-footpad areas (Table 1). The main difference
between footpad and non-footpad areas is the thickness of the
epidermal layer. If sprouting is induced by scratching
(Yamaoka et al., 2007), and if the footpad areas, which are
located more superﬁcially, would receive most of the
mechanical damage induced by the scratching, this would
then lead to an earlier appearance of ﬁber sprouting.
Nerve ﬁber density during chronic itch and inﬂammation
In all three models, we have observed either an increase or a
no signiﬁcant change in the epidermal nerve ﬁber density as
compared with control but never a signiﬁcant decrease, in
agreement with previous studies (Tominaga et al., 2007;
Almarestani et al., 2008). We further showed that the increase
in ﬁber density is primarily due to an increase in peptidergic
ﬁbers. The non-peptidergic ﬁber density remained unchanged,
except for a small but a signiﬁcant increase in the dry skin
model. The increase in the peptidergic ﬁber density in the skin
is most likely due to the sprouting of ﬁbers caused by the
expression of growth factors, especially neurotrophic growth
factor (NGF; Diamond et al., 1992), which may also cause the
increased expression of peptides in the dorsal root ganglion
(DRG; Basbaum et al., 2009). An important source for the
production of NGF in the skin during inﬂammation (with or
without itch; Watanabe et al., 2008; Kamo et al., 2011;
Raap et al., 2011) are keratinocytes (Di Marco et al., 1991).
Because NGF preferentially acts on TrkA and/or p75
receptors, which are expressed by peptidergic but not by
non-peptidergic ﬁbers (Basbaum et al., 2009), an increase in
NGF would lead to an increased number of peptidergic ﬁbers
(Kaplan et al., 1991). Moreover, in patients suffering from
atopic dermatitis, high levels of plasma NGF have been
reported (Toyoda et al., 2002) possibly accounting for the
increase in peptidergic ﬁber density. These ﬁndings are in
agreement with our observations that show a strong increase
in the density of peptidergic ﬁbers in all three models.
Moreover, the expression of trophic factors such as NGF and
glia-cell–derived neurotrophic factor (GDNF), which are
produced by keratinocytes (Di Marco et al., 1991), is
increased speciﬁcally in the epidermis in different patho-
logical skin conditions (Tokime et al., 2008; Kamo et al.,
2011). This may explain our observation that there is a
selective increase in nerve ﬁbers in the epidermis, where the
highest concentration of growth factors is present.
The ﬁnding that the CFA and the dermatitis models showed
a similar pattern of peptidergic nerve ﬁber sprouting, without
a change in the non-peptidergic ﬁbers, is in line with the signs
of inﬂammation that were present in both models. However,
the two models differed with regard to the scratching
behavior, which only occurred in the dermatitis model. Thus,
in these models, the scratching behavior—that is, the
presence of itch—is not reﬂected in a difference in the
sprouting behavior of the peptidergic and the non-peptidergic
ﬁbers. Recent ﬁndings have shown that the cytokine thymic
stromal lymphopoeitin, which is released by keratinocytes in
atopic dermatitis, evokes itch behavior by direct activation of
sensory neurons (Wilson et al., 2013). Thus, it seems likely
that the itch observed in the dermatitis model is caused by
release of thymic stromal lymphopoeitin in the skin and that
this release does not occur in the CFA model. Another
cytokine that is increased in the skin in atopic dermatitis is
IL-31 (Sonkoly et al., 2006), which also induced itch through
direct activation of the receptor IL-31A (Cevikbas et al., 2014),
which is expressed by peripheral nerve ﬁbers (Kato et al.,
2014). CFA induced inﬂammation was found to increase the
expression of the P2X3 receptor in trigeminal (Yasuda et al.,
2012) and spinal (Xu and Huang, 2002) in DRG cells. This
increase is not reﬂected in a change in the density of the
peripheral P2X3-expressing ﬁbers in the dermatitis and
inﬂammation models, indicating that the correlation between
the expression of P2X3 in the DRG cells and nerve ﬁber
density in the periphery is not straightforward. It has been
suggested that increased P2X3 expression in ganglion cells
occurs speciﬁcally in the soma to subserve intra-ganglionic
signaling (Amir and Devor, 2000). Furthermore, most
changes in the DRG cells return to normal within 2 weeks
(Ambalavanar et al., 2005) possibly because the peripheral
expression of GDNF, which is likely involved in the DRG
changes, also returns to normal within that period (Fang et al.,
2003). In contrast, the present study was focused on long-term
changes (2 weeks and 4 weeks) and may not reﬂect short-term
changes in ganglion cells.
Taken together, our ﬁndings seem to indicate that the
sprouting of ﬁbers is, by itself, not leading to itch. Instead, it
seems more likely that itch is induced by local mediators like
thymic stromal lymphopoeitin and IL-31. On the other hand,
it was found in a mice dermatitis model (Negi et al., 2012) that
scratching behavior was reduced in mice that were treated
with Semaphorin A3, a nerve repulsion factor that prevents
nerve ﬁber sprouting.
In the CFA and dermatitis models, the increase in ﬁber
density was exclusively due to an increase in peptidergic
ﬁbers. However, in the dry skin model, there was also a small
but a signiﬁcant increase in the non-peptidergic ﬁbers. In the
present study, non-peptidergic ﬁbers were identiﬁed by their
expression of the P2X3 receptor, but these ﬁbers are also
characterized by their expression of the RET-receptor and its
co-receptor GFR-α1 and are therefore speciﬁcally sensitive to
the growth factor GDNF (Basbaum et al., 2009). Therefore,
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the selective increase in the non-peptidergic ﬁbers in the dry
skin model may be due to an increased expression of GDNF,
which stimulates the sprouting of non-peptidergic ﬁbers in the
skin (Zwick et al., 2002). It is presently unknown whether
GDNF in the skin is increased in the dry skin model.
However, in an IL-18 dermatitis model, GDNF levels were
increased (Tokime et al., 2008), whereas in another inﬂam-
matory model GDNF was not increased (Xu et al., 2005)
indicating that GDNF may only increase in speciﬁc types of in
inﬂamed skin. As non-peptidergic ﬁbers were increased only
in the dry skin model, we propose that dry skin leads to an
increase in GDNF in the skin and that this increase does not
occur in the dermatitis model nor in the inﬂammation model.
One of the key questions regarding the role of sensory ﬁbers
in chronic itch is whether or not their sprouting is causative of
itch. Our ﬁndings show that, in the case of the peptidergic
ﬁbers, there is an increased density during chronic inﬂamma-
tion without behavioral signs of itch. On the basis of this
ﬁnding, we conclude that the increase in nerve ﬁber density is
not invariably associated with the presence of itch. The
absence of an increase in non-peptidergic ﬁbers during itch in
the dermatitis model also points in this direction.
We have shown that only peptidergic ﬁbers are increased
during inﬂammation and dermatitis, whereas both peptidergic
ﬁbers and, to a lesser extent, non-peptidergic ﬁbers are
increased in dry skin disease. These differential changes in
nerve ﬁber density may be used in future as a diagnostic tool,
through skin biopsies, to identify different types of skin
pathology and changes induced by speciﬁc therapies.
MATERIALS AND METHODS
Animal models
A total of 42 male Wistar rats weighing between 250 and 300 g were
used in this study. All experiments were approved by the Dutch
Ethical Committee on Animal Welfare (DEC), and all procedures
were in accordance to the European guidelines for the care and use
of laboratory animals (Council Directive 86/6009/EEC).
Chronic dry skin was induced following a previously reported
procedure (Akiyama et al., 2010) in which a mixture of acetone and
diethylether (1:1) was applied daily on the foot sole of the left hind
paw for 30 seconds immediately followed by the application of
distilled water for 30 seconds using a cotton gauze.
In order to induce chronic dermatitis, dinitrochlorobenzene
(Nacalai Tesque, Kyoto, Japan) dissolved in acetone to make a 3%
solution was applied three times per week on the foot sole of the left
hind paw for 60 seconds using a cotton gauze (Fujii et al., 2009).
Chronic inﬂammation was induced by injection of 100 μl of a com-
plement Freund adjuvans (Sigma-Aldrich, Seelze, Germany) solution
in the foot sole of the left hind paw at the start of the experiments.
The control group was treated three times per week with distilled
water applied with a cotton gauze to the left foot sole for 60 seconds.
Behavioral experiments
Scratching behavior was assessed with the 4-week survival once a
week by one observer for a period of 30 minutes by placing the rat in
a plastic box. The mechanical thresholds of the affected hind paws
were measured once a week during the entire survival period using
von Frey monoﬁlaments (Stoelting, Wood Dale, IL), as described
previously (Duraku et al., 2013; See Supplementary data online for
details).
Immunohistochemistry
After survival periods of 2 or 4 weeks, the animals received an
overdose of pentobarbital (100mg kg− 1), and immediately thereafter
the foot soles of the treated hind limbs were dissected and were
immersion ﬁxed in 2% paraformaldehyde-lysine-periodate for
24 hours at 4 °C. Thereafter, the skins were embedded in gelatin
blocks (10% sucrose) and post ﬁxed in 4% formaldehyde and 30%
sucrose (Ruigrok and Apps, 2007). Subsequently, transverse sections
were cut at 40 μm using a freezing microtome and collected serially
in eight glycerol (30%) containing vials for long-term storage
at − 20 °C.
The hemotoxylin and eosin staining was performed according to
standard protocol. For immunohistochemistry, sections were pro-
cessed as described earlier (Duraku et al., 2013). In short, the
following steps were applied with rinsing in phosphate-buffered
saline between the steps. The sections were pre-treated with 3%
hydrogen peroxide solution at room temperature for 10 minutes and
heated in at 80 °C for 40minutes in a solution of 2.5 mM sodium
citrate (pH 8.75) to unmask the epitopes (Jongen et al., 2007).
Subsequently, sections were pre-incubated (90minutes at room
temperature) in a blocking solution containing BSA (2%) and 0.5%
Triton X-100 (Roche, Basel, Switzerland) incubated for 48 hours in a
cocktail of 2% BSA or milk powder containing the diluted antibody at
4 °C. The primary antibodies were SubP (1/500, rabbit (Buijs et al.,
1989), CGRP (1/30,000 rabbit, Calbiochem, Darmstadt, Germany)
P2X3 (1/25,000, rabbit, Neuromics, Edina, MN) and PGP9.5
(1/10,000, rabbit, Enzo Life Sciences, Lausen, Switzerland), CD68
(1/10,000, mouse, Bioconnect, Huissen, The Netherlands). Sub-
sequently, sections were incubated with the appropriate secondary
biotinylated antibody (1/200, Vector Laboratories, Burlinghame, CA)
for 90minutes. Sections were further processed using a Vectastain
Elite ABC kit (90 minutes at room temperature, Vector Laboratories),
and additional signal ampliﬁcation was achieved by treating the
sections with self-made biotin tyramide (Hopman et al., 1998)
for 12minutes. The 3,-3′ diaminobenzidine (Vector Laboratories)
reaction, enhanced by the glucose–3,-3′ diaminobenzidine method
(Kuhlmann and Peschke, 1986), was used to reveal antigenic sites.
Thereafter, the sections were mounted randomly on gelatinized
slides and dehydrated using absolute ethanol (o0.01% methanol),
transferred to xylene, and coverslipped with Permount.
Analysis
The number of nerve ﬁber endings present in the epidermis and in the
upper dermis was counted in the sections using an Olympus BH
microscope equipped with a Lucivid miniature monitor and Neuro-
lucida software (MicroBrightField, Colchester, VT). The ﬁbers were
identiﬁed manually by one observer in sections that were blinded. The
number of epidermal and upper dermal ﬁbers was counted using a
20× objective in a 750-μm wide region in the footpad and the non-
footpad areas of the foot sole. For each rat, 16 sections through the
rostral and caudal footpad were counted. From these counts the
number of nerve ﬁbers per mm2 was calculated for each rat. Per group
(n=6) the results were averaged and compared with the results in the
control group. In order to determine statistical differences in ﬁber
density the one-way analysis of variance with a Tukey post hoc test
BN Schüttenhelm et al.
Skin Innervation During Chronic Itch and Inﬂammation
www.jidonline.org 2055
was used for intergroup comparisons. The method of analysis for the
behavioral experiments is described in the Supplementary data section
online. Errors in variations were determined as SEM, and Po0.05 was
taken as signiﬁcant. The sections stained with hematoxylin and eosin
and processed for CD68 immunohistochemistry were assessed
together by a certiﬁed pathologist at the Erasmus MC.
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